A Systematic Review and Meta-Analysis of the Efficacy and Safety of Xinbao Pill in Chronic Heart Failure
Wang Y, Liu Y, Liu Z, Cheng Y, Wang D · Frontiers in Pharmacology · 2022 March 02
DOI 10.3389/fphar.2022.846867
Objective
This study aimed to clarify the efficacy and safety of Xinbao pill (XBP) as an adjunctive treatment for chronic heart failure (CHF).
Conclusions
This study indicated that Xinbao pill (XBP) as adjunctive therapy combined with conventional medicine seemed to be safe and more effective than conventional medicine alone in treating chronic heart failure (CHF).
Critical Appraisal
Published research can offer valuable insights, but a paper’s conclusions may go beyond what its results support. Critical appraisal examines the methods, findings and limitations to clarify what can reasonably be concluded—and what remains uncertain.
This article has not yet been critically appraised by the Research Hub.
Learn more about Critical Appraisal
